NCT06261944View on ClinicalTrials.gov

A Pivotal Clinical Investigation Confirming the Safety and Accuracy of the Glyconics-DS in Assessment of Glycated Nail Keratin in Individuals With Unknown Diabetes Status and Performance Evaluation of the Glyconics SW Package

NAActive, not recruitingINTERVENTIONAL
Enrollment

486

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

May 21, 2024

Study Completion Date

August 8, 2024

Conditions
Pre-diabetesUndiagnosed Diseases
Interventions
DEVICE

Near-infrared (NIR)

Near-infrared assessment of glycated keratin in middle fingernail

Trial Locations (1)

Unknown

Sant Pau Hospital, Barcelona

Sponsors

Lead Sponsor

Glyconics Ltd
All Listed Sponsors
lead

Glyconics Ltd

INDUSTRY

NCT06261944 - A Pivotal Clinical Investigation Confirming the Safety and Accuracy of the Glyconics-DS in Assessment of Glycated Nail Keratin in Individuals With Unknown Diabetes Status and Performance Evaluation of the Glyconics SW Package | Biotech Hunter | Biotech Hunter